Evidence for continuous glucose monitoring: Sufficient for reimbursement?

Diabetic Medicine

Volumn 31, Issue 2, 2014, Pages 122-125

  Heinemann, L ^a   Devries, J H ^b  

^a Science and Co   (Germany)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CONTINUOUS GLUCOSE MONITORING; COST EFFECTIVENESS ANALYSIS; DIAGNOSIS; GLUCOSE SENSOR; HEALTH CARE SYSTEM; HUMAN; HYPOGLYCEMIA; INFORMATION PROCESSING; INSULIN INFUSION; INSULIN PUMP; LEARNING CURVE; META ANALYSIS (TOPIC); PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; BLOOD; COST BENEFIT ANALYSIS; DIABETES MELLITUS; ECONOMICS; EVIDENCE BASED PRACTICE; PROCEDURES;

BLOOD GLUCOSE SELF-MONITORING; COST-BENEFIT ANALYSIS; DIABETES MELLITUS; EVIDENCE-BASED PRACTICE; HUMANS; INSULIN; INSULIN INFUSION SYSTEMS; INSURANCE, HEALTH, REIMBURSEMENT;

EID: 84892560719     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12341     Document Type: Article

References (14)

1. Langendam MW, Luijf YM, Hooft L, DeVries JH, Mudde AH, Scholten RJ. Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev 2012; 1: CD008101.
2. Heinemann L, Franc S, Phillip M, Battelino T, Ampudia-Blasco FJ, Bolinder J et al. Reimbursement for continuous glucose monitoring: a European view. J Diabetes Sci Technol 2012; 6: 1498-1502.
3. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J et al. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther 2008; 10: 377-383.
4. Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane W, Vigersky R et al. Continuous glucose monitoring: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 2968-2979.
5. Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real-time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. Br Med J 2011; 343: d3805.
6. Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008; 359: 1464-1476.
7. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010; 363: 311-320.
8. Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013; 369: 224-232.
9. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011; 34: 795-800.
10. 1c in suboptimally controlled Type 1 diabetes; a randomized controlled trial. Diabet Med 2011; 28: 1158-1167.
11. Danne T, Kordonouri O, Holder M, Haberland H, Golembowski S, Remus K et al. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther 2011; 13: 1129-1134.
12. Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 2013; 310: 1240-1247.
13. Choudhary P, Ramasamy S, Brackenridge A, Green L, Gallen P, Pender S et al. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care 2013; doi: 10.2337/dc13-0939 [Epub ahead of print].
14. Huang ES, O'Grady M, Basu A, Winn A, John P, Lee J et al. The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care 2010; 33: 1269-1274.